| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6344215 | AYTU BIOPHARMA | Methylphenidate modified release formulations |
Oct, 2020
(3 years ago) | |
Metadate Cd is owned by Aytu Biopharma.
Metadate Cd contains Methylphenidate Hydrochloride.
Metadate Cd has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Metadate Cd are:
- US6344215
Metadate Cd was authorised for market use on 27 May, 2003.
Metadate Cd is available in capsule, extended release;oral dosage forms.
The generics of Metadate Cd are possible to be released after 27 October, 2020.
Drugs and Companies using METHYLPHENIDATE HYDROCHLORIDE ingredient
Market Authorisation Date: 27 May, 2003
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of METADATE CD before it's drug patent expiration?
More Information on Dosage
METADATE CD family patents
